1. Clinical Outcome of the Patients With Brain Metastasis from Soft Tissue Sarcomas
- Author
-
Yohei Kawakami, Tomoyuki Matsumoto, Yuichi Hoshino, Teruya Kawamoto, Takahiro Niikura, Kenichiro Kakutani, Kazumichi Kitayama, Ikuo Fujita, Masayuki Morishita, Takuya Fujimoto, Shuichi Fujiwara, Hitomi Hara, Toshiyuki Takemori, Toshihiro Akisue, Tomohiro Miyamoto, Ryosuke Kuroda, Takehiko Matsushita, Yutaka Mifune, Naomasa Fukase, and Shunsuke Yahiro
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Postoperative radiotherapy ,Alveolar soft part sarcoma ,medicine ,Humans ,Rhabdomyosarcoma ,Aged ,Retrospective Studies ,Myxoid liposarcoma ,Brain Neoplasms ,business.industry ,Medical record ,Soft tissue ,Sarcoma ,General Medicine ,Middle Aged ,medicine.disease ,Survival Analysis ,Surgery ,Oncology ,Female ,Radiotherapy, Adjuvant ,business ,Brain metastasis - Abstract
Background/aim This study aimed to evaluate the association of clinical characteristics with treatment outcomes to ascertain the appropriate treatment options for soft tissue sarcomas (STS) patients with brain metastasis (BM). Patients and methods Medical records of STS patients with BM who were treated in our institutions were retrospectively reviewed, and analyzed to identify the factors associated with post-BM survival. Results Among the 509 STS patients, BM occurred in five patients (0.98%). The median survival after BM was 1.5 months. Histological subtypes of the primary lesions in the five BM patients were: two synovial sarcomas, one myxoid liposarcoma, one alveolar soft part sarcoma, and one rhabdomyosarcoma. Among the five BM patients, the post-BM survival of two patients, who underwent surgery and postoperative radiotherapy, was longer than that of the other patients (p Conclusion Combined surgery and postoperative radiotherapy effectively managed symptoms and prolonged survival in STS patients with BM.
- Published
- 2021
- Full Text
- View/download PDF